Milica Margeta, M.D., Ph.D.




English, Croatian

Board Certification

  • Pending

East Bridgewater
400 N. Bedford Street
E. Bridgewater, MA 02333
Phone: 617-573-3202
Accepting New Patients
800 Huntington Ave.
Boston, MA 02115
Phone: 617-573-3202
Accepting New Patients
Accepting New Patients



Dr. Milica Margeta is a member of the Mass. Eye and Ear Glaucoma Service, where she specializes in medical and surgical management of moderate and advanced glaucoma.

Dr. Margeta earned her MD and PhD from Stanford University, and attended Duke University for her ophthalmology residency and glaucoma fellowship. During residency, she received the prestigious Robert Machemer Resident Research Award for her project "CSF protein levels in children with idiopathic intracranial hypertension (IIH)," as well as the Duke Ocular Innovation Award for creating a novel approach for adjusting glaucoma drainage device surgery in children with glaucoma.

As a K12 Scholar in the Harvard Vision Clinical Scientist Development Program, which is funded by the National Institutes of Health/National Eye Institute, Dr. Margeta is interested in developing novel neuroprotective strategies in glaucoma, a chronic degenerative disease that damages the eye's optic nerve and can lead to progressive loss of vision. In particular, she is studying the role of macrophages and microglia during glaucomatous optic nerve damage. These immune cells are known to play both pro-inflammatory and anti-inflammatory, reparative roles in a variety of tissues depending on their activation state. Therefore, maintaining these cells in the neuroprotective form has the potential to lead to the development of new therapies, which may repair damaged tissue and/or prevent vision loss in patients with glaucoma

Clinical Interests

Moderate, advanced and complex glaucoma

Research Interests

Glaucoma, inflammation, neuroprotection, macrophages/microglia


For a full publications list, please see her CV.

Low cerebrospinal fluid protein in prepubertal children with idiopathic intracranial hypertension. Margeta MA, Buckley EG, El-Dairi M. J AAPOS. 2015;19:135-9.

Molecular mechanisms of synaptic specificity. Margeta MA, Shen K. Mol Cell Neurosci. 2010;43:261-7

Clathrin adaptor AP-1 complex excludes multiple postsynaptic receptors from axons in C. elegans. Margeta MA, Wang GJ, Shen K. Proc Natl Acad Sci USA. 2009;106:1632-7

Building a synapse: lessons on synaptic specificity and presynaptic assembly from the nematode C. elegans.  Margeta, MA, Shen, K, Grill B. Curr Opin Neurobiol. 2008;18:69-76

Glia promote local synaptogenesis through UNC-6 (netrin) signaling in C. elegans. Colón-Ramos DA, Margeta MA, Shen K. Science. 2007; 318: 103-6.

View a complete list of publications on>>



  • Biological Science, Stanford University, BS
  • Neuroscience, Stanford University, Ph.D.
  • Stanford University, M.D.


  • Ophthalmology, Duke University


  • Glaucoma, Duke University